16-2065541-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000548.5(TSC2):​c.1622C>A​(p.Pro541Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P541R) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)

Consequence

TSC2
NM_000548.5 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.370
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.09973973).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TSC2NM_000548.5 linkuse as main transcriptc.1622C>A p.Pro541Gln missense_variant 16/42 ENST00000219476.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TSC2ENST00000219476.9 linkuse as main transcriptc.1622C>A p.Pro541Gln missense_variant 16/425 NM_000548.5 P49815-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Tuberous sclerosis 2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 04, 2023This sequence change replaces proline, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 541 of the TSC2 protein (p.Pro541Gln). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TSC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 406013). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TSC2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 10, 2022The p.P541Q variant (also known as c.1622C>A), located in coding exon 15 of the TSC2 gene, results from a C to A substitution at nucleotide position 1622. The proline at codon 541 is replaced by glutamine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.0058
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
11
DANN
Benign
0.94
DEOGEN2
Uncertain
0.49
T;.;.;.;.;.;.;.;.;.;.;.;T;.;T
Eigen
Benign
-0.91
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.39
N
LIST_S2
Uncertain
0.95
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.10
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.4
L;.;.;.;L;L;.;.;.;L;.;L;.;.;.
MutationTaster
Benign
1.0
N;N;N;N;N;N;N
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.8
N;.;.;N;.;N;.;.;N;N;.;.;.;.;N
REVEL
Benign
0.29
Sift
Benign
0.18
T;.;.;T;.;T;.;.;T;T;.;.;.;.;T
Sift4G
Benign
0.17
T;.;.;T;.;T;.;.;T;T;.;.;.;.;T
Polyphen
0.090
B;.;.;.;B;B;.;.;B;B;.;.;.;.;.
Vest4
0.41
MutPred
0.29
Loss of catalytic residue at P541 (P = 0.0098);Loss of catalytic residue at P541 (P = 0.0098);Loss of catalytic residue at P541 (P = 0.0098);.;Loss of catalytic residue at P541 (P = 0.0098);Loss of catalytic residue at P541 (P = 0.0098);Loss of catalytic residue at P541 (P = 0.0098);Loss of catalytic residue at P541 (P = 0.0098);.;Loss of catalytic residue at P541 (P = 0.0098);Loss of catalytic residue at P541 (P = 0.0098);Loss of catalytic residue at P541 (P = 0.0098);Loss of catalytic residue at P541 (P = 0.0098);Loss of catalytic residue at P541 (P = 0.0098);.;
MVP
0.63
ClinPred
0.17
T
GERP RS
2.1
Varity_R
0.065
gMVP
0.17

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs752953762; hg19: chr16-2115542; API